Also trades as: 0241.HK (HKSE) · $vol 35M · ALBHF (OTC) · $vol 0M

$7.04

-0.73 (-9.45%)

Weekly Expected Move ±7.4%

$6 $7 $7 $8 $8

OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 38 · $5.7B mcap · 293M float · 0.0002% daily turnover · Short 39% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$33.2B +8.5% ▲

5Y CAGR: +16.4%

Gross Profit

$8.0B +7.0% ▲

5Y CAGR: +17.1%

Operating Income

$1.8B +12.8% ▲

5Y CAGR: +97.9%

Net Income

$1.9B +31.0% ▲

5Y CAGR: +40.0%

EPS (Diluted)

$2.40 +34.8% ▲

5Y CAGR: +35.8%

EBITDA

$1.8B +12.9% ▲

5Y CAGR: +103.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$20.6B	$26.8B	$27.0B	$30.6B	$33.2B
YoY Growth	+32.6%	+30.1%	+1.0%	+13.2%	+8.5%
Cost of Revenue	$16.5B	$21.1B	$21.1B	$23.2B	$25.2B
Gross Profit	$4.1B	$5.7B	$5.9B	$7.4B	$8.0B
Gross Margin	20.0%	21.3%	21.8%	24.3%	24.0%
R&D Expenses	$729M	$678M	$705M	$720M	$764M
SG&A Expenses	$2.4B	$2.1B	$2.1B	$2.6B	$5.4B
Operating Expenses	$5.1B	$5.7B	$5.2B	$5.9B	$6.2B
Operating Income	-$1.1B	-$32M	$640M	$1.6B	$1.8B
Operating Margin	-5.3%	-0.1%	2.4%	5.2%	5.4%
Interest Expense	$4M	$6M	$6M	$3M	$1M
Income Before Tax	-$253M	$551M	$939M	$1.6B	$2.2B
Tax Expense	$13M	$14M	$56M	$128M	$327M
Net Income	-$266M	$536M	$883M	$1.4B	$1.9B
Net Margin	-1.3%	2.0%	3.3%	4.7%	5.7%
EPS (Diluted)	$-0.39	$0.79	$1.25	$1.78	$2.40
EBITDA	-$188M	-$24M	$999M	$1.6B	$1.8B
Shares Outstanding	674M	677M	705M	807M	810M

Line Item	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$15.3B	$13.0B	$14.1B	$14.3B	$8.2B	$16.3B	$16.5B	$17.2B
Cost of Revenue	$11.9B	$10.1B	$11.0B	$10.7B	$6.2B	$12.4B	$12.4B	$13.3B
Gross Profit	$3.4B	$2.9B	$3.0B	$3.5B	$1.9B	$3.9B	$4.1B	$4.0B
Gross Margin	22.3%	22.1%	21.5%	24.8%	23.9%	23.9%	25.0%	22.9%
R&D Expenses	$354M	$319M	$386M	$319M	$200M	$401M	$310M	$467M
SG&A Expenses	$3.0B	$2.3B	$1.1B	$2.4B	$1.4B	$2.8B	$2.7B	$2.8B
Operating Expenses	$3.2B	$2.6B	$2.6B	$2.7B	$1.6B	$3.2B	$3.0B	$3.3B
Operating Income	-$13M	$260M	$379M	$785M	$347M	$693M	$1.1B	$703M
Operating Margin	-0.1%	2.0%	2.7%	5.5%	4.2%	4.2%	6.7%	4.1%
Interest Expense	$0	$0	$0	$0	$0	$0	$680K	$702K
Income Before Tax	$377M	$481M	$458M	$821M	$369M	$739M	$1.4B	$830M
Tax Expense	$4M	$36M	$20M	$52M	$38M	$76M	$161M	$172M
Net Income	$373M	$446M	$438M	$769M	$332M	$663M	$1.3B	$657M
Net Margin	2.4%	3.4%	3.1%	5.4%	4.1%	4.1%	7.6%	3.8%
EPS (Diluted)	$0.55	$0.66	$0.60	$0.96	$0.41	$0.82	$1.57	$0.83
EBITDA	-$575K	$272M	$389M	$786M	$350M	$700M	$1.5B	$732M
Shares Outstanding	678M	678M	731M	805M	809M	809M	810M	810M

ALBBY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet